Novel Glycosaminoglycan Precursors as Anti-Amyloid Agents Part II

By Kisilevsky Robert   Szarek Walter A.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 45-50

Humana Press, Inc

Access to resources Recommend Favorite

Novel glycosaminoglycan precursors as anti-amyloid agents, Part III

By Kisilevsky Robert   Szarek Walter   Ancsin John   Bhat Shridhar   Li Zhanjiang   Marone Sandra  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 291-297

Humana Press, Inc

Access to resources Recommend Favorite

Human anti--amyloid antibodies block -amyloid fibril formation and prevent -amyloid-induced neurotoxicity

By Farlow M.  

Brain, Vol. 126, Iss. 9, 2003-09 ,pp. : 1935-1939

Oxford University Press

Access to resources Recommend Favorite

Beneficial effect of human anti-amyloid- active immunization on neurite morphology and tau pathology

By Serrano-Pozo Alberto  

Brain, Vol. 133, Iss. 5, 2010-05 ,pp. : 1312-1327

Oxford University Press

Access to resources Recommend Favorite

RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine

By  

Current Alzheimer Research, Vol. 3, Iss. 3, 2006-07 ,pp. : 221-227

Bentham Science Publishers

Access to resources Recommend Favorite